Drug Target Review – Issue #1 2016

In Issue #1 2016 of Drug Target Review:

• FOREWORD: Using computational models to aid drug discovery
  Jon Timmis, Chief Executive Officer, SimOmics Ltd
• MICROFLUIDICS: The fur-free way towards personalised medicine in cancer therapy
  Amy Dawson,Victoria Green, Ruth Bower and John Greenman, University of Hull
• PROTEIN EXPRESSION: Pushing the limits of protein expression with miRNAs
  Simon Fischer, Boehringer Ingelheim, and Rene Handrick and Kerstin Otte, Biberach University of Applied Sciences
• DRUG TARGETS IN-DEPTH FOCUS
  With contributions from Jean-Marie Frère and Sébastien Rigali, Université de Liège, Ken McGarry, Anuam Rashid and Hannah Smith, University of Sunderland, and Sheraz Gul and Maria Kuzikov, Fraunhofer-IME SP
• BIOMARKERS: Strategies for identifying predictive biomarkers of nonalcoholic fatty liver disease
  Wasco Wruck, Marie-Ann Kawala, Nina Graffmann and James Adjaye, Heinrich-Heine-University
• ONCOLOGY: Classifying brain tumours to improve diagnoses
  Xiaolong Fan, Beijing Normal University
• ASSAYS IN-DEPTH FOCUS
  With articles from David Shum, Institut Pasteur Korea, Gabriele Sorg, Hit Discovery Constance and Horst Flotow, Singapore Screening Centre
• ANTIBODIES IN-DEPTH FOCUS
  With features from Carol Harley, IBMC and i3S, Ricardo S. Vieira-Pires, University of Coimbra and Sukmook Lee, Scripps Korea Antibody Institute